Disorders of lung matrix remodelling

Journal of Clinical Investigation

Volumn 113, Issue 2, 2004, Pages 148-157

  Chapman, Harold A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; LEUKOTRIENE; THROMBIN; THROMBOPLASTIN; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ADULT RESPIRATORY DISTRESS SYNDROME; BRONCHIOLITIS; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE MUTATION; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG SARCOIDOSIS; NONHUMAN; OCULAR ALBINISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR; ANIMAL; AUDIOVISUAL EQUIPMENT; BIOLOGICAL MODEL; CHEMISTRY; DISEASE COURSE; DISEASE MODEL; EPITHELIUM; FIBROSIS; GENETICS; INFLAMMATION; LUNG; LUNG DISEASE; METABOLISM; MOUSE; MUTATION; PATHOLOGY;

ANIMALS; COLLAGEN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIUM; FIBROSIS; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES; MICE; MODELS, ANATOMIC; MODELS, BIOLOGICAL; MUTATION; PULMONARY FIBROSIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85047694529     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20729     Document Type: Review

References (103)

1. Jeffery, P.K. 2001. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164:S28-S38.
2. Tiddens, H., Silverman, M., and Bush, A. 2000. The role of inflammation in airway disease: remodeling. Am. J. Respir. Crit. Care Med. 162:S7-S10.
3. Green, F.H. 2002. Overview of pulmonary fibrosis. Chest. 122:334S-339S.
4. Heffner, J.E., Brown, L.K., Barbieri, C.A., Harpel, K.S., and DeLeo, J. 1995. Prospective validation of an acute respiratory distress syndrome predictive score. Am. J. Respir. Crit. Care Med. 152:1518-1526.
5. Martin, C., Papazian, L., Payan, M.J., Saux, P., and Gouin, F. 1995. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest. 107:196-200.
6. Tomashefski, J.F., Jr. 2000. Pulmonary pathology of acute respiratory distress syndrome. Clin. Chest Med. 21:435-466.
7. Shimabukuro, D.W., Sawa, T., and Gropper, M.A. 2003. Injury and repair in lung and airways. Crit. Care Med. 31:S524-S531.
8. 2002. American Thoracic Society and European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001, and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 165:277-304.
9. Sulica, R., Teirstein, A., and Padilla, M.L. 2001. Lung transplantation in interstitial lung disease. Curr. Opin. Pulm. Med. 7:314-322.
10. Estenne, M., and Hertz, M.I. 2002. Bronchiolitis obliterans after human lung transplantation. Am. J. Respir. Crit. Care Med. 166:440-444.
11. Pandit-Bhalla, M., Diethelm, L., Ovella, T., Sloop, G.D., and Valentine, V.G. 2003. Idiopathic interstitial pneumonias: an update. J. Thorac. Imaging. 18:1-13.
12. Weinberger, S.E., et al. 1978. Bronchoalveolar lavage in interstitial lung disease. Ann. Intern. Med. 89:459-466.
13. Keogh, B.A., and Crystal, R.G. 1982. Alveolitis: the key to the interstitial lung disorders. Thorax. 37:1-10.
14. Peters-Golden, M. 2003. Arachidonic acid metabolites: potential mediators and therapeutic targets in fibrotic lung disease. In Idiopathic pulmonary fibrosis. J.P. Lynch III, editor. Marcel Dekker Inc. New York, New York, USA. 421-452.
15. Phan, S.H., McGarry, B.M., Loeffler, K.M., and Kunkel, S.L. 1988. Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry. 27:2846-2853.
16. Yamamoto, T., Eckes, B., Mauch, C., Hartmann, K., and Krieg, T. 2000. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. J. Immunol. 164:6174-6179.
17. Pittet, J.F., et al. 2001. TGF-beta is a critical mediator of acute lung injury. J. Clin. Invest. 107:1537-1544.
18. Keane, M.P., et al. 2002. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome. J. Immunol. 169:6515-6521.
19. Kunkel, S.L., Lukacs, N., and Strieter, R.M. 1995. Chemokines and their role in human disease. Agents Actions Suppl. 46:11-22.
20. Smith, R. E., et al. 1995. A role for C-C chemokines in fibrotic lung disease. J. Leukoc. Biol. 57:782-787.
21. Belperio, J.A., et al. 2001. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans. J. Clin. Invest. 108:547-556. doi:10.1172/JCI200112214.
22. Krein, P.M., Sabatini, P.J., Tinmouth, W., Green, F.H., and Winston, B.W. 2003. Localization of insulin-like growth factor-I in lung tissues of patients with fibroproliferative acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 167:83-90.
23. Reichenberger, F., et al. 2001. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases. Lung. 179:163-174.
24. Homma, S., et al. 1995. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am. J. Respir. Crit. Care Med. 152:2084-2089.
25. Kuhn, C., III, et al. 1989. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis. 140:1693-1703.
26. Fukuda, Y., et al. 1987. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am. J. Pathol. 126:171-182.
27. Gross, T.J., Simon, R.H., and Sitrin, R.G. 1992. Tissue factor procoagulant expression by rat alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 6:397-403.
28. Idell, S. 2003. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit. Care Med. 31:S213-S220.
29. Chapman, H.A., Stahl, M., Allen, C.L., Yee, R., and Fair, D.S. 1988. Regulation of the procoagulant activity within the bronchoalveolar compartment of normal human lung. Am. Rev. Respir. Dis. 137:1417-1425.
30. Marshall, B.C., et al. 1991. Alveolar epithelial cells express both plasminogen activator and tissue factor. Potential role in repair of lung injury. Chest. 99:25S-27S.
31. Marshall, R.P., et al. 2000. Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am. J. Respir. Crit. Care Med. 162:1783-1788.
32. Pugin, J., Verghese, G., Widmer, M.C., and Matthay, M.A. 1999. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit. Care Med. 27:304-312.
33. Chesnutt, A.N., Matthay, M.A., Tibayan, F.A., and Clark, J.G. 1997. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am. J. Respir. Crit. Care Med. 156:840-845.
34. Carmeliet, P., et al. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:419-424.
35. Teder, P., et al. 2002. Resolution of lung inflammation by CD44. Science. 296:155-158.
36. Lambrecht, B.N., Prins, J.B., and Hoogsteden, H.C. 2001. Lung dendritic cells and host immunity to infection. Eur. Respir. J. 18:692-704.
37. Martin, T.R., Nakamura, M., and Matute-Bello, G. 2003. The role of apoptosis in acute lung injury. Crit. Care Med. 31:S184-S188.
38. Uhal, B.D. 2002. Apoptosis in lung fibrosis and repair. Chest. 122:293S-298S.
39. Kuwano, K., et al. 1999. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. Am. J. Respir. Cell Mol. Biol. 20:53-60.
40. Albertine, K.H., et al. 2002. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Pathol. 161:1783-1796.
41. Kuwano, K., et al. 2002. Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases. Respirology. 7:15-21.
42. Wang, R., Zagariya, A., Ang, E., Ibarra-Sunga, O., and Uhal, B.D. 1999. Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction. Am. J. Physiol. 277:L1245-L1250.
43. Chen, J.J., Sun, Y., and Nabel, G.J. 1998. Regulation of the proinflammatory effects of Fas ligand (CD95L). Science. 282:1714-1717.
44. Park, D.R., et al. 2003. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J. Immunol. 170:6209-6216.
45. Warburton, D., et al. 2001. Do lung remodeling, repair, and regeneration recapitulate respiratory ontogeny? Am. J. Respir. Crit. Care Med. 164:S59-S62.
46. Warburton, D., Zhao, J., Berberich, M.A., and Bernfield, M. 1999. Molecular embryology of the lung: then, now, and in the future. Am. J. Physiol. 276:L697-L704.
47. Costa, R.H., Kalinichenko, V.V., and Lim, L. 2001. Transcription factors in mouse lung development and function. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L823-L838.
48. Sakai, T., Larsen, M., and Yamada, K.M. 2003. Fibronectin requirement in branching morphogenesis. Nature. 423:876-881.
49. Watkins, D.N., et al. 2003. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature. 422:313-317.
50. Pepicelli, C.V., Lewis, P.M., and McMahon, A.P. 1998. Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr. Biol. 8:1083-1086.
51. Muller, T., Bain, G., Wang, X., and Papkoff, J. 2002. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp. Cell Res. 280:119-133.
52. Chilosi, M., et al. 2003. Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis. Am. J. Pathol. 162:1495-1502.
53. Morrisey, E.E. 2003. Wnt signaling and pulmonary fibrosis. Am. J. Pathol. 162:1393-1397.
54. Dunsmore, S.E., et al. 1998. Matrilysin expression and function in airway epithelium. J. Clin. Invest. 102:1321-1331.
55. Zuo, F., et al. 2002. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl. Acad. Sci. U. S. A. 99:6292-6297.
56. Iwano, M., et al. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341-350. doi:10.1172/JCI200215518.
57. Yang, J., and Liu, Y. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159:1465-1475.
58. Adamson, I.Y. 1984. Drug-induced pulmonary fibrosis. Environ. Health Perspect. 55:25-36.
59. Haston, C.K., et al. 2002. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum. Mol. Genet. 11:1855-1863.
60. Kaminski, N., et al. 2000. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc. Natl. Acad. Sci. U. S. A. 97:1778-1783.
61. Kelly, M., Kolb, M., Bonniaud, P., and Gauldie, J. 2003. Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm. Des. 9:39-49.
62. Munger, J.S., et al. 1999. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:319-328.
63. Murphy-Ullrich, J.E., and Poczatek, M. 2000. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 11:59-69.
64. Mu, D., et al. 2002. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J. Cell Biol. 157:493-507.
65. Dallas, S.L., Rosser, J.L., Mundy, G.R., and Bonewald, L.F. 2002. Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J. Biol. Chem. 277:21352-21360.
66. Massague, J., and Chen, Y.G. 2000. Controlling TGF-beta signaling. Genes Dev. 14:627-644.
67. Zeng, X., Gray, M., Stahlman, M.T., and Whitsett, J.A. 2001. TGF-beta1 perturbs vascular development and inhibits epithelial differentiation in fetal lung in vivo. Dev. Dyn. 221:289-301.
68. Gauldie, J., Sime, P.J., Xing, Z., Marr, B., and Tremblay, G.M. 1999. Transforming growth factor-beta gene transfer to the lung induces myofibroblast presence and pulmonary fibrosis. Curr. Top. Pathol. 93:35-45.
69. Huang, M., et al. 2002. IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis. J. Clin. Invest. 109:931-937. doi:10.1172/ JCI200214685.
70. Ziesche, R., Hofbauer, E., Wittmann, K., Petkov, V., and Block, L.H. 1999. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 341:1264-1269.
71. Kalra, S., Utz, J.P., and Ryu, J.H. 2003. Interferon gamma-1b therapy for advanced idiopathic pulmonary fibrosis. Mayo Clin. Proc. 78:1082-1087.
72. Thannickal, V.J., et al. 2003. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 278:12384-12389.
73. Bhowmick, N.A., Zent, R., Ghiassi, M., McDonnell, M., and Moses, H.L. 2001. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276:46707-46713.
74. Hayashida, T., Decaestecker, M., and Schnaper, H.W. 2003. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J. 17:1576-1578.
75. Chen, Y., et al. 2002. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 62:1149-1159.
76. Janda, E., et al. 2002. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156:299-313.
77. Eitzman, D.T., et al. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97:232-237.
78. Olman, M.A., Mackman, N., Gladson, C.L., Moser, K.M., and Loskutoff, D.J. 1995. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J. Clin. Invest. 96:1621-1630.
79. Sisson, T.H., et al. 2002. Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L1023-L1032.
80. Kotani, I., et al. 1995. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb. Res. 77:493-504.
81. Chapman, H.A., Allen, C.L., and Stone, O.L. 1986. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev. Respir. Dis. 133:437-443.
82. Hattori, N., et al. 2000. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J. Clin. Invest. 106:1341-1350.
83. Chambers, R-C., Leoni, P., Blanc-Brude, O.P., Wembridge, D.E., and Laurent, G.J. 2000. Thrombin is a potent inducer of connective tissue growth factor production via proteolyric activation of protease-activated receptor-1. J. Biol. Chem. 275:35584-35591.
84. Ruf, W., and Riewald, M. 2003. Tissue factor-dependent coagulation protease signaling in acute lung injury. Crit. Care Med. 31:S231-S237.
85. Howell, D.C., et al. 2001. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 159:1383-1395.
86. Howell, D.C., Laurent, G.J., and Chambers, R.C. 2002. Role of thrombin and its major cellular receptor, protease-activated receptor-1, in pulmonary fibrosis. Biochem. Soc. Trans. 30:211-216.
87. Kobayashi, H., et al. 1998. Protein C anticoagulant system in patients with interstitial lung disease. Am. J. Respir. Crit. Care Med. 157:1850-1854.
88. Keerthisingam, C.B., et al. 2001. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 158:1411-1422.
89. Nagase, T., et al. 2002. A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat. Med. 8:480-484.
90. Peters-Golden, M., et al. 2002. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am. J. Respir. Crit. Care Med. 165:229-235.
91. Wilborn, J., et al. 1996. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest. 97:1827-1836.
92. Ricupero, D.A., Rishikof, D.C., Kuang, P.P., Poliks, C.F., and Goldstein, R.H. 1999. Regulation of connective tissue growth factor expression by prostaglandin E(2). Am. J. Physiol. 277:L1165-L1171.
93. Moore, B.B., et al. 2001. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J. Immunol. 167:4368-4377.
94. Nogee, L.M., et al. 2001. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 344:573-579.
95. Thomas, A.Q., et al. 2002. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 165:1322-1328.
96. Glasser, S.W., et al. 2003. Pneumonitis and emphysema in sp-C gene targeted mice. J. Biol. Chem. 278:14291-14298.
97. Brantly, M., et al. 2000. Pulmonary, function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest. 117:129-136.
98. Nakatani, Y., et al. 2000. Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch. 437:304-313.
99. Latsi, P.I., et al. 2003. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med. 168:531-537.
100. Flaherty, K.R., et al. 2003. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am. J. Respir. Crit. Care Med. 167:1410-1415.
101. Ware, L.B., Fang, X., and Matthay, M.A. 2003. Protein C and thrombomodulin in human acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L514-L521.
102. Greene, K.E., et al. 2002. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J. 19:439-446.
103. Takahashi, H., et al. 2000. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 162:1109-1114.